Using a digital lifestyle tool to prevent cardiovascular events
Secondary Prevention of Cardiovascular Disease With the Lifestyle Tool
This study is testing whether a digital lifestyle tool can help people who have had a heart attack make lasting changes to their habits and reduce their chances of future heart problems.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 11000 (estimated) |
| Ages | 35 Years to 80 Years |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Malmö) |
| Trial ID | NCT05309876 on ClinicalTrials.gov |
What this trial studies
This study involves participants who have experienced a myocardial infarction being randomized to either use a digital lifestyle tool for three years or to a control group without access to the tool. The aim is to evaluate the long-term efficacy of this web-based tool in promoting sustainable lifestyle changes and reducing the incidence of major cardiovascular events. The study addresses the need for innovative and cost-effective lifestyle interventions that can be integrated into existing healthcare systems, focusing on patient autonomy and motivation. Participants will be followed prospectively to assess outcomes related to cardiovascular health.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 35 to 80 who have had a myocardial infarction within the past year and have access to a computer or mobile phone.
Not a fit: Patients with conditions or treatments that may interfere with the study evaluation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention strategies for patients with a history of myocardial infarction, potentially reducing the risk of future cardiovascular events.
How similar studies have performed: While previous studies have shown promise in lifestyle interventions for cardiovascular disease, this study aims to fill gaps in long-term efficacy and cost-effectiveness, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 35 to 80 years * myocardial infarction within one year prior to enrolment * access to computer or mobile phone. Exclusion Criteria: * conditions or treatments that in the judgement of the Investigator could affect the study evaluation
Where this trial is running
Malmö
- Skane University Hospital — Malmö, Sweden (Recruiting)
Study contacts
- Principal investigator: Anders Rosengren, Professor — Göteborg University
- Study coordinator: Birgitta Abrahamsson
- Email: birgitta.x.abrahamsson@skane.se
- Phone: 0705316704
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.